Avidity Partners Management LP

Avidity Partners Management LP reported 18 holdings worth US$488M as of Sep 30, 2026 (Form 13F)

As of Sep 30, 2026 · Filed Nov 16, 2026

Avidity Partners Management LP reported 18 holdings worth US$488M as of Sep 30, 2026. Largest: Dianthus Therapeutics, Inc., CG Oncology, Inc. and Oruka Therapeutics, Inc. Filed Nov 16, 2026 (Form 13F).

Holdings
18
Value as reported
US$488M

The filing in full

CompanySharesValue as reported% of portfolio
Dianthus Therapeutics, Inc.1.9MUS$167M34.3%
CG Oncology, Inc.1.35MUS$95.6M19.6%
Oruka Therapeutics, Inc.785KUS$65.4M13.4%
Jade Biosciences, Inc.2MUS$28.1M5.8%
Enliven Therapeutics, Inc.550KUS$25.2M5.2%
Perspective Therapeutics, Inc.6.07MUS$16.7M3.4%
Aktis Oncology, Inc.484KUS$9.43M1.9%
Immunic, Inc.670KUS$6.23M1.3%
Mobia Medical, Inc.325KUS$3.07M0.63%
Palvella Therapeutics, Inc.20,000US$2.76M0.57%
Nuvectis Pharma, Inc.100KUS$2.12M0.43%
Satellos Bioscience Inc164KUS$1.39M0.29%
Context Therapeutics Inc.4.06MUS$1.22M0.25%
Karyopharm Therapeutics Inc.885KUS$1.08M0.22%
Senseonics Holdings, Inc.100KUS$1.02M0.21%
Avalyn Pharma Inc.20,000US$570K0.12%
Genmab A/S0US$00.00%
Gilead Sciences, Inc.0US$00.00%
Insulet Corporation0US$00.00%
Intellia Therapeutics, Inc.0US$00.00%
Kailera Therapeutics, Inc.0US$00.00%
Peloton Interactive, Inc.0US$00.00%
Phathom Pharmaceuticals, Inc.0US$00.00%
Repligen Corporation0US$00.00%
Savara, Inc.0US$00.00%
Tempus AI, Inc.0US$00.00%
Tenax Therapeutics, Inc.0US$00.00%
Teva Pharmaceutical Industries Limited0US$00.00%
Trevi Therapeutics, Inc.0US$00.00%
Vir Biotechnology, Inc.0US$00.00%
Abbott Laboratories0US$00.00%
Alamar Biosciences, Inc.0US$00.00%
Boston Scientific Corporation0US$00.00%
BridgeBio Oncology Therapeutics, Inc.0US$00.00%
BridgeBio Pharma, Inc.0US$00.00%
Charles River Laboratories International, Inc.0US$00.00%
Corvus Pharmaceuticals, Inc.0US$00.00%
DexCom, Inc.0US$00.00%
Encompass Health Corporation0US$00.00%
Evommune, Inc.0US$00.00%

Source

Download original · View original at SEC

Related